Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The pursuit of real-time, high-resolution imaging at visible wavelength has long been hampered by the limitations of traditional laser sources. Existing visible ultrafast lasers often suffer from limited repetition rates, or complex pulse shaping requirements, hindering their applicability for advanced imaging techniques. This work introduces a novel ultrafast imaging technology using a 775 nm near visible Kerr frequency comb. Kerr frequency combs arise from the formation of stable localized dissipative structures in coherently driven Kerr resonators. Compared to conventional visible lasers, Kerr frequency combs offer unique advantages, such as adjustable spectral bandwidth, precise frequency control, and robust coherence. Particularly, Kerr frequency combs generated using a synchronously pumped scheme can offer flexible repetition rates from the order of hundreds of MHz to tens of GHz, overcoming the limited repetition rates of the existing visible imaging lasers. In this work, we realize a Kerr frequency comb source centred at 775 nm through switching wave generation and use this source in a proof-of-concept demonstration of ultrafast biological imaging. Experimentally, we are able to achieve a 500 MHz line-scan rate and demonstrate a new approach to high speed imaging of biological samples with unprecedented speed and versatility. We envisage our work will pave the way for exciting new discoveries in various fields, propelling us closer to a future where ultrafast dynamics can be visualized in real-time and with exquisite detail.

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.551627DOI Listing

Publication Analysis

Top Keywords

kerr frequency
24
frequency comb
12
repetition rates
12
frequency combs
12
visible ultrafast
8
ultrafast imaging
8
synchronously pumped
8
switching wave
8
existing visible
8
limited repetition
8

Similar Publications

Background: In ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), an invasive strategy demonstrated better health status outcomes than a conservative strategy in patients with chronic coronary disease (CCD). Some previous studies have shown greater health status benefits with coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI). Whether the health status benefits of invasive management in ISCHEMIA were driven primarily by participants treated with CABG is unknown.

View Article and Find Full Text PDF

The epilepsy deaths register: Third-party reports of SUDEP in adults and older adolescents.

Seizure

August 2025

Royal Victoria Infirmary, Newcastle-upon-Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. Electronic address:

Objective: The major source for sudden unexpected death in epilepsy (SUDEP) case series has been medical case record review, however most deaths occur at home, with no clinical witness. We set out to describe SUDEP characteristics using reports of deaths from third-parties and explore the effectiveness of this reporting as a sampling technique.

Methods: We collected characteristics of the deceased and narratives surrounding death via the SUDEP Action UK Epilepsy Deaths Register (EDR).

View Article and Find Full Text PDF

Aim: To inform and support clinical, operational and public health nursing leaders by describing a nurse-led Vaccine Volunteer Program (VVP) preceptorship model that improved rapid and safe access to care and can serve as a replicable and scalable framework for future disaster response scenarios.

Design: This brief report describes a strategic service-learning response that innovatively allowed nursing students to be force multipliers in responding to urgent community vaccination needs.

Method: Student eligibility was determined by a VVP coordinator, who then assigned students to a site and preceptor.

View Article and Find Full Text PDF

Background: Few large-scale population studies have examined both safety and vaccine effectiveness (VE) specifically for 5-11-year-olds during the Omicron-dominant period in a setting with low vaccine uptake. The BNT162b2 (Pfizer-BioNTech) vaccine, administered in two doses, has shown strong efficacy against symptomatic and severe COVID-19 in clinical trials involving children and young people (CYP). Accordingly, we examined the uptake, real-world safety, VE, and waning of BNT162b2 VE against symptomatic COVID-19 among children aged 5-11 years in Scotland.

View Article and Find Full Text PDF